Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Seliciclib by Cyclacel Pharmaceuticals for Rheumatoid Arthritis: Likelihood of Approval
Seliciclib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase...
Data Insights
Seliciclib by Cyclacel Pharmaceuticals for Rheumatoid Arthritis: Likelihood of Approval
Seliciclib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase...